Why are some amyloidoses systemic? Does hepatic “chaperoning at a distance” prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?-Reference-Cited by-同舟云学术

Why are some amyloidoses systemic? Does hepatic “chaperoning at a distance” prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?

Published:2012-02-23 Issue:6 Volume:26 Page:2283-2293
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Buxbaum Joel N.¹,Tagoe Clement²,Gallo Gloria³,Walker John R.⁴,Kurian Sunil¹,Salomon Daniel R.¹

Affiliation:

1. Department of Molecular and Experimental MedicineThe Scripps Research InstituteLa JollaCaliforniaUSA

2. Department of MedicineAlbert Einstein College of MedicineBronxNew YorkUSA

3. Department of PathologyNew York University School of MedicineNew YorkNew YorkUSA

4. The Functional Genomics Institute of the Novartis FoundationLa JollaCaliforniaUSA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.11-189571

Reference37 articles.

1. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis

2. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

3. Adapting Proteostasis for Disease Intervention

4. The Biological and Chemical Basis for Tissue-Selective Amyloid Disease

5. An Adaptable Standard for Protein Export from the Endoplasmic Reticulum

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?;Clinical Research in Cardiology;2024-08-21

2. A mouse model of cardiac AL amyloidosis unveils mechanisms of tissue accumulation and toxicity of amyloid fibrils;2024-07-22

3. Aging in Heart Failure;JACC: Heart Failure;2024-05

4. Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy;Heart Failure Reviews;2024-01-18

5. Emerging Roles for Dendritic Cells in Heart Failure;Biomolecules;2023-10-17